NanoTemper Technologies Launches Spectral Shift, a Breakthrough Technology That Changes the Game for Affinity-Based Screenings
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--NanoTemper Technologies announced today the launch of Spectral Shift technology within their Dianthus instrument, built to handle the most challenging affinity-based screenings in drug discovery. This breakthrough technology removes the roadblocks experienced by scientists dealing with really complex molecular interactions often seen in challenging drugs and...
